Alnylam Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R.
ALNY Key Statistics
Stock Snapshot
Alnylam Pharmaceuticals(ALNY) stock is priced at $240.07, giving the company a market capitalization of 32.1B. It carries a P/E multiple of 39.85.
On 2026-08-26, Alnylam Pharmaceuticals(ALNY) stock moved within a range of $235.41 to $240.67. With shares now at $240.07, the stock is trading +2.0% above its intraday low and -0.2% below the session's peak.
Trading volume for Alnylam Pharmaceuticals(ALNY) stock has reached 1.58M, versus its average volume of 1.69M.
The stock's 52-week range extends from a low of $197.81 to a high of $495.55.
The stock's 52-week range extends from a low of $197.81 to a high of $495.55.
ALNY News
Alnylam Pharmaceuticals has had a difficult run over the past year, with the share price down 46.8%, while the current valuation checks still lean toward the st...
Alnylam (ALNY) Pharmaceuticals announced that it will present new clinical and real-world data across its transthyretin-mediated amyloidosis, ATTR, and hyperten...
In late July 2026, Alnylam Pharmaceuticals cut its full-year TTR product sales guidance after reassessing growth expectations for the ATTR-CM market, prompting...
Analyst ratings
75%
of 32 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.